# Intermediate Risk Cervical Cancer: Radical Surgery +/- Adjuvant Radiotherapy

> **NCT04989647** · PHASE3 · RECRUITING · sponsor: **The Central and Eastern European Gynecologic Oncology Group** · enrollment: 514 (estimated)

## Conditions studied

- Cervical Cancer

## Interventions

- **RADIATION:** No adjuvant therapy
- **RADIATION:** Adjuvant radiotherapy

## Key facts

- **NCT ID:** NCT04989647
- **Lead sponsor:** The Central and Eastern European Gynecologic Oncology Group
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-06-10
- **Primary completion:** 2029-12
- **Final completion:** 2032-12
- **Target enrollment:** 514 (ESTIMATED)
- **Last updated:** 2023-09-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04989647

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04989647, "Intermediate Risk Cervical Cancer: Radical Surgery +/- Adjuvant Radiotherapy". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04989647. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*